Patients in the UK currently prescribed Crescent Pharma Limited Ramipril 2.5mg capsules are being advised to inspect their medication packaging following a precautionary recall. The recall, issued due to a packaging error, specifically targets batch number GR155023. The concern is that some blister strips within the 2.5mg capsule packaging may be incorrectly labelled as Ramipril 10mg.
Ramipril is a widely prescribed medication belonging to a class of drugs called ACE inhibitors, commonly used to treat high blood pressure (hypertension), heart failure, and to protect the heart and kidneys in individuals at risk of cardiovascular events, such as those who have had a heart attack or stroke. It works by relaxing blood vessels, which lowers blood pressure and makes it easier for the heart to pump blood around the body.
The Medicines and Healthcare products Regulatory Agency (MHRA) often oversees such recalls to ensure patient safety. While the specific details of how the error occurred have not been disclosed, such incidents typically involve issues during the manufacturing or packaging process where different strengths of medication are handled on the same production line. It is crucial for patients to understand that this is a precautionary measure to prevent potential dosing errors.
Individuals who find that their Crescent Pharma Limited Ramipril 2.5mg capsules (batch number GR155023) contain blister strips labelled as Ramipril 10mg should not immediately stop taking their medication. Instead, they should contact their local pharmacy or dispensing doctor's surgery for advice on how to proceed. It is important to continue taking prescribed medication unless advised otherwise by a healthcare professional, as abruptly stopping blood pressure medication can have adverse health effects.
The NHS recommends that patients with concerns about their medication should always speak to a healthcare professional. For non-urgent enquiries, patients can consult their GP or pharmacist. In cases requiring immediate medical advice, NHS 111 is available. The recall highlights the importance of checking medication packaging, even for routine prescriptions, to ensure the correct dosage is being administered.
This recall affects a specific product from one manufacturer and does not imply any issue with other brands or strengths of Ramipril. Patients taking Ramipril from different manufacturers or different strengths of Crescent Pharma Limited Ramipril are not impacted by this particular alert.